PVR _ CD155 _ NECL5 Protein
- Known as:
- PVR _ CD155 _ NECL5 Protein
- Catalog number:
- 10109-H02H
- Product Quantity:
- 100
- Category:
- -
- Supplier:
- Smart Serology
- Gene target:
- PVR _ CD155 NECL5 Protein
Related genes to: PVR _ CD155 _ NECL5 Protein
- Gene:
- PVR NIH gene
- Name:
- PVR cell adhesion molecule
- Previous symbol:
- PVS
- Synonyms:
- CD155, HVED, Necl-5, NECL5, Tage4
- Chromosome:
- 19q13.31
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2019-03-14
Related products to: PVR _ CD155 _ NECL5 Protein
Related articles to: PVR _ CD155 _ NECL5 Protein
- Prosthetic pulmonary valve endocarditis (PPVE) limits survival and quality of life in patients with repaired congenital heart disease. We describe patient outcomes with PPVE in a single center and the application of transcatheter pulmonary valve replacement (TPVR). - Source: PubMed
Publication date: 2026/07/20
Ruiz Solano ElyanBreithaupt Jason JSoszyn NatalieShad Joanna MZablah JennyMorgan GarethLeahy RyanTaylor AnneFraser Charles DDowns Emily AJaggers JamesStone Matthew L - Patients who underwent either transurethral resection of the prostate (TURP) or bladder neck incision (BNI) for bladder outlet obstruction (BOO) were evaluated in this study. The aim was to compare the perioperative characteristics and postoperative outcomes of the two surgical approaches. - Source: PubMed
Publication date: 2026/09/25
Yeni SezginKilciler MeteAy NurullahVarisli BehcetGonullu Sinan - To evaluate the safety and functional outcomes of transperineal laser ablation (TPLA) in men with large prostates (>80 mL), with specific focus on perioperative events, catheter-related outcomes, and mid-term efficacy. - Source: PubMed
Conte Francesco LSaladino MarcoLambertini LucaGajo LeonardoKucuku NelianaConte FrancescaGiustozzi BeatriceFerretti RiccardoPosanzini SimoneMazzola LucaSalamone VincenzoCarli GiuliaLipparini FilippoLeo FedericaFahoum MaroD'Ermo MarcoCarmona Garcia Jhosep JDI Maida FabrizioVittori GianniGrosso Antonio AMinervini AndreaMari Andrea - Minimally invasive surgical therapies (MIST) aim to relieve lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) while preserving sexual and ejaculatory function. We prospectively assessed semen parameters up to 18 months after prostatic urethral lift (PUL) in men under 50 prioritizing ejaculation and contextualized these findings against other MIST. - Source: PubMed
D'Altilia NicolaSecco SilviaGuzzi FrancescoRicapito AnnaFinati MarcoMazzotta LorenzoBusetto Gian MBettocchi CarloCarrieri GiuseppeAnnese Pasquale - RNA sequencing (RNA-seq) analysis revealed transcriptional features indicative of sustained immunosuppression within regulatory T cells (Tregs) isolated from atherosclerotic tissues, highlighting the critical contribution of immune checkpoint (ICP) receptor-ligand interactions to atherosclerosis progression. To comprehensively characterize the roles of ICP signaling in this context, we integrated transcriptomic profiling, quantitative RT-PCR, and flow cytometry analysis, yielding several key findings: (1) Multiomics integration revealed global transcriptomic alterations in ICP receptors and ligands across diverse tissues, immune cell types, and disease stages in both human and murine models of atherosclerosis; (2) Several ICP components demonstrated functional relevance, including dual-function ligand CD155 (PVR); inhibitory ligands Lgals3 and Itgb1; stimulatory ligands Tnfrsf9 and CD48; and inhibitory receptors Havcr2 and Lair1. These molecules act as microenvironmental sensors, dynamically responding to atherosclerotic cues; (3) Experimental validation confirmed upregulation of the CD155-TIGIT axis within immune cells of atherosclerotic plaques. Notably, CD155 expression positively correlated with CD206 expression in both CD11bCD11c and CD11bCD11c cells, irrespective of tissue context; and (4) The CD206+ macrophages/DCs-CD155-TIGIT Treg axis emerged as a potential ICP-mediated pathway that confers immunoregulatory protection against atherosclerosis progression. Collectively, these findings uncover novel immunomodulatory roles for ICP ligands in atherosclerosis, expanding their known functions beyond adaptive immune regulation to include modulation of innate immune responses within atherosclerotic lesions. - Source: PubMed
Publication date: 2026/09/17
Shao YingSaaoud FatmaIssa Mohammed BenXu KemanLu YifanHung Shih-YuLiu JuanjuanYuan BoWei JunchengWu ShengMohsin SadiaZhou ZhengjieKosmider BeataMartinez LaiselVazquez-Padron RobertoWang HongYang Xiaofeng